Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASKP1240 in de novo kidney transplant recipients
NCT01780844Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2013
- Primary completion
- Jun 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bleselumab in transplant rejection, sponsored by Astellas Pharma. Started Mar 2013; status: completed.
02
Drugs
bleselumab
03
Conditions
transplant rejection
Beyond the preview
Go deeper on NCT01780844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780844.